A complete application in a minute
Tailored resume and cover letter, ready to send.
Sandoz in Warsaw, Poland, is seeking a Medical Advisor to shape medical strategy across assigned therapeutic areas within a hybrid work setup. You will contribute to Brand Strategies, ensure proper documentation, and train team members while engaging with stakeholders and global medical affairs.
Key responsibilities include leading KOL plans, providing cross-functional medical expertise, reviewing regulatory materials, and supporting market access with robust medical inputs.
Job Description Summary Sandoz is going through an exciting and transformative period as a global leader and pioneering provider of sustainable Biosimilar and Generic medicines. By creating a new and ambitious path, it will provide a unique opportunity for us all, both professionally and personally.
Medical Advisor contributes to the development of medical strategy and provides Medical input into Brand Strategies and medical guidance and governance for all assigned therapeutic areas ensuring support during products life cycle all along.
This role works to execute the medical component of the Brand Strategies, ensure relevant team members are properly trained, and ensures medical efforts are properly documented.
Join us !
Sandoz compensation is determined by job level, qualifications, niche skills, experience, and location within company salary ranges. Fully proficient and highly effective employees can expect a starting salary around market median, with those new to the level or with less functional depth at the lower end of the range and those with sustained superior or niche skills towards the higher end of the range. Internal equity and external market data inform our range placement. Annual salary reviews consider performance outcomes, market alignment, and business needs.
Job location : Warsaw, Poland
Work mode: hybrid
Pay range (monthly salary) : gross/zł 15 209 - 28 241
Pay frequency : monthly
Expected weekly working hours : 40h
Contract type: Fixed-term contract
Generic and Biosimilar medicines are the backbone of the global medicines industry. Sandoz, a leader in this sector, provided more than 900 million patient treatments across 100+ countries in 2024 and while we are proud of this achievement, we have an ambition to do more! With investments in new development capabilities, production sites, new acquisitions, and partnerships, we have the opportunity to shape the future of Sandoz and help more patients gain access to low-cost, high-quality medicines, sustainably